Clinical trial

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

NCT00849082

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention cyproterone acetate Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record goserelin acetate Normalized identity: goserelin acetateView linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1987-05-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

cyproterone acetateDRUG

goserelin acetateDRUG · verified · RxNorm: goserelin acetate

radiation therapyRADIATION

Sponsors & collaborators

European Organisation for Research and Treatment of Cancer - EORTClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00849082 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.